Assay ID | Title | Year | Journal | Article |
AID1387301 | Inhibition of human ALDH1A1 | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1387327 | Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells at 1 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1387300 | Inhibition of ALDH (unknown origin) | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826435 | Cytotoxicity against human H415/15 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1826433 | Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1199901 | Inhibition of recombinant human ALDH1A1 using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis | 2015 | Journal of medicinal chemistry, Feb-26, Volume: 58, Issue:4
| Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. |
AID1199888 | Inhibition of human ALDH1A1 G458N mutant using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis | 2015 | Journal of medicinal chemistry, Feb-26, Volume: 58, Issue:4
| Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. |
AID1826437 | Cytotoxicity against human H431/14 LM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1387333 | Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in CD133 protein expression incubated for 48 hrs by CD133/2-APC antibody based assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826438 | Cytotoxicity against human H488/14 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1826434 | Antiproliferative activity against human DU145 cells expressing ALDH1A1 assessed as reduction in cell survival measured after 96 hrs by MTT assay | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1387314 | Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826422 | Inhibition of N-terminal-His6 tagged recombinant human ALDH3A1 assessed as reduction in NADPH production using 4-NBA and NADP+ as substrate by fluorimetric analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1826421 | Inhibition of N-terminal-His6 tagged recombinant human ALDH1A3 assessed as reduction in NADH production using hexanal and NAD+ as substrate by fluorimetric analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1387328 | Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells at 10 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1387334 | Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in CD133 protein expression incubated for 48 hrs by CD133/2-APC antibody based assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1387330 | Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in aldefluor positive cells at 10 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826439 | Cytotoxicity against human H517/15 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1387315 | Inhibition of ALDH1A1 in human MIAPaCa2 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1387316 | Inhibition of ALDH1A1 in human HT-29 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826436 | Cytotoxicity against human H568/15 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1387329 | Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in aldefluor positive cells at 1 uM incubated for 30 mins by aldefluor assay | 2018 | Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
| Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. |
AID1826419 | Inhibition of N-terminal-His6 tagged recombinant human ALDH1A1 assessed as remaining enzyme activity by measuring fluorescence of NADH using hexanal and NAD+ as substrate at 10 uM by fluorimetric analysis relative to control | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1826420 | Inhibition of N-terminal-His6 tagged recombinant human ALDH1A1 assessed as reduction in NADH production using hexanal and NAD+ as substrate by fluorimetric analysis | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
AID1826432 | Antiproliferative activity against human PC-3 cells expressing ALDH1A1 and ALDH3A1 assessed as reduction in cell survival measured after 96 hrs by MTT assay | 2022 | Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |